[1]施国富,吴春阳,施亚明,等.血浆脑钠肽对射血分数保留心力衰竭患者的诊断价值研究[J].医学信息,2018,31(16):47-50.[doi:10.3969/j.issn.1006-1959.2018.16.013]
　SHI Guo-fu,WU Chun-yang,SHI Ya-ming,et al.Diagnostic Value of Plasma Brain Natriuretic Peptide in Patients with Heart Failure Preserved by Ejection Fraction[J].Journal of Medical Information,2018,31(16):47-50.[doi:10.3969/j.issn.1006-1959.2018.16.013]
点击复制

血浆脑钠肽对射血分数保留心力衰竭患者的诊断价值研究()

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年16期
页码:
47-50
栏目:
论著
出版日期:
2018-08-15

文章信息/Info

Title:
Diagnostic Value of Plasma Brain Natriuretic Peptide in Patients with Heart Failure Preserved by Ejection Fraction
文章编号:
1006-1959（2018）16-0047-04
作者:
施国富; 吴春阳; 施亚明; 杨顺清
盐城市第三人民医院心内科，江苏 盐城 224005
Author(s):
SHI Guo-fu; WU Chun-yang; SHI Ya-ming; YANG Shun-qing
Department of Cardiology,Third People's Hospital of Yancheng,Yancheng 224005,Jiangsu,China
关键词:
心力衰竭; 脑钠肽; 超声心动图; 受试者工作特征曲线
Keywords:
Key words：Heart failure; Brain natriuretic peptide; Echocardiography; Receiver operating characteristic curve
分类号:
R541.6
DOI:
10.3969/j.issn.1006-1959.2018.16.013
文献标志码:
A
摘要:
目的 探讨射血分数保留心力衰竭患者的血浆脑钠肽变化及其诊断价值。方法 收集2015年1月～2018年1月江苏省盐城市第三人民医院心内科收治的69例无症状舒张功能不全患者（ADD）、射血分数保留心力衰竭（HFPEF）患者为研究对象。均行BNP检测及超声心动图检查，利用受试者工作特征曲线（ROC）分析BNP对HFPEF的诊断价值。结果 与ADD组患者相比，HFPEF患者的超声心动图指标LVEDD、IVST、LVPWT、LAd、E值较大，Ad值较小，差异具有统计学意义（P＜0.05）。但两组患者的LVEF、LVESD、E/A、DT、IVRT、PVs2、PVd、PVa、PVad，差异无统计学意义（P＞0.05）。相关性研究结果显示，LVEDD、IVST、LVPWT、LAd、LAV水平与血浆BNP水平呈正相关关系（P＜0.05），LVEF、IVRT与血浆BNP水平呈负相关关系（P＜0.05）。NYHAⅡ级、Ⅲ级、Ⅳ级患者的BNP水平分别为（86.6±34.6）pg/ml、（376.6±248.8）pg/ml、（1347±643）pg/ml，差异具有统计学意义（F=764.12，P＜0.001）。ROC曲线检验结果显示，曲线下面积为0.844，以BNP=131.2 pg/ml为界值，对HFPEF诊断的敏感性为80.70%，特异性为73.60%。结论 HFPEF患者血浆BNP水平显著更高，且BNP水平与超声心动图指标有一定的相关关系，对HFPEF有一定的诊断价值。
Abstract:
Abstract：Objective To investigate the changes of plasma brain natriuretic peptide and its diagnostic value in patients with heart failure by ejection fraction.Methods From January 2015 to January 2018,69 patients with asymptomatic diastolic dysfunction(ADD) and ejection fraction retention heart failure(HFPEF)were enrolled in the Department of Cardiology,Yancheng Third People's Hospital, Jiangsu province.Both BNP and echocardiography were performed,and the receiver operating characteristic curve(ROC)was used to analyze the diagnostic value of BNP for HFPEF.Results Compared with ADD group,LVEDD,IVST,LVPWT,LAd,E value of HFPEF patients were higher,and the value of Ad was smaller,the difference was statistically significant(P<0.05).However,there were no significant differences in LVEF,LVESD,E/A,DT,IVRT,PVs2,PVd,PVa and PVad between the two groups(P>0.05).Correlation study showed that LVEDD,IVST,LVPWT,LAd,LAV levels were positively correlated with plasma BNP levels (P<0.05),and LVEF and IVRT were negatively correlated with plasma BNP levels (P<0.05).The BNP levels of NYHAI I,III,and IV patients were(86.6±34.6)pg/ml, (376.6±248.8)pg/ml,(1347±643)pg/ml,and the difference was statistically significant(F=764.12,P<0.001).The ROC curve test showed that the area under the curve was 0.844,which was bounded by BNP=131.2pg/ml.The sensitivity to the diagnosis of HFPEF was 80.70% and the specificity was 73.60%.Conclusion The plasma BNP level of HFPEF patients is significantly higher,and the BNP level has a certain correlation with echocardiographic index,which has certain diagnostic value for HFPEF.

参考文献/References:

[1]董洪玲,王中鲁,张亮,等.慢性心力衰竭的治疗进展[J].中国循证心血管医学杂志,2017,9(2):246-248.
[2]杨金球. N末端B型脑肽在诊断左心射血分数正常心力衰竭中的应用价值研究[J].中医临床研究,2017,9(18):43-45.
[3]王洁妤,华琦.左心室射血分数保留的心力衰竭研究进展[J]. 中华老年心脑血管病杂志,2016,18(7):766-769.
[4]中华医学会心血管病学分会.中国心力衰竭诊断和治疗指南2014[J].中华心血管病杂志,2014,42(2):3-10.
[5]徐芳芳.自我效能联合健康教育对慢性心力衰竭患者干预的临床效果分析[J].现代实用医学,2017,29(9):1235-1236.
[6]吉杨.急诊PCI联合rh-BNP治疗对急性前壁心肌梗死患者神经内分泌指标及心功能的影响[J].海南医学院学报,2016,22(11):1054-1057.
[7]问文敏,孙光,张潇怡,等.射血分数正常的心力衰竭老年患者的肾功能改变及其临床意义[J].中国医科大学学报,2015,44(7):618-621.

相似文献/References:

[1]郭俊林,张立.BNP对CRT后期疗效的临床评价[J].医学信息,2018,31(01):67.[doi:10.3969/j.issn.1006-1959.2018.01.024]
　GUO Jun-lin,ZHANG li.Clinical Evaluation of BNP in Treatment of Late CRT[J].Journal of Medical Information,2018,31(16):67.[doi:10.3969/j.issn.1006-1959.2018.01.024]
[2]程 林.重组人脑利钠肽用于重症急性心肌炎伴 心力衰竭患者治疗的临床研究[J].医学信息,2018,31(08):126.[doi:10.3969/j.issn.1006-1959.2018.08.042]
　CHENG Lin.Clinical Study of Recombinant Human Brain Natriuretic Peptide in the Treatment of Patients with Severe Acute Myocarditis and Heart Failure[J].Journal of Medical Information,2018,31(16):126.[doi:10.3969/j.issn.1006-1959.2018.08.042]
[3]胡丽君.螺内酯联合曲美他嗪治疗慢性心力衰竭的疗效分析[J].医学信息,2018,31(08):131.[doi:10.3969/j.issn.1006-1959.2018.08.044]
　HU Li-jun.Efficacy of Spironolactone Combined with Trimetazidine in the Treatment of Chronic Heart Failure[J].Journal of Medical Information,2018,31(16):131.[doi:10.3969/j.issn.1006-1959.2018.08.044]
[4]李 铎,王建华.盐酸曲美他嗪片辅助治疗对冠心病伴心力衰竭患者氧化应激、心肌功能的影响[J].医学信息,2018,31(10):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
　LI Duo,WANG Jian-hua.Effect of Trimetazidine Hydrochloride Tablets Adjuvant Therapy on Oxidative Stress and Myocardial Function in Patients with Coronary Heart Disease Complicated with Heart Failure[J].Journal of Medical Information,2018,31(16):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
[5]平兰芝,黄小楼,胡天俊,等.CaMKⅡ在心血管疾病中的研究[J].医学信息,2022,35(10):59.[doi:10.3969/j.issn.1006-1959.2022.10.014]
　PING Lan-zhi,HUANG Xiao-lou,HU Tian-jun,et al.Research on the Role of CaMKⅡ in Cardiovascular Diseases[J].Journal of Medical Information,2022,35(16):59.[doi:10.3969/j.issn.1006-1959.2022.10.014]
[6]刘革铭,马洪俊,刘 毅,等.心力衰竭的机制及诊疗的研究[J].医学信息,2022,35(10):91.[doi:10.3969/j.issn.1006-1959.2022.10.022]
　LIU Ge-ming,MA Hong-jun,LIU Yi,et al.Mechanism, Diagnosis and Treatment of Heart Failure[J].Journal of Medical Information,2022,35(16):91.[doi:10.3969/j.issn.1006-1959.2022.10.022]
[7]黄光明,赵兴昌,符显昭.水中运动联合中药内治对糖尿病大鼠心肌细胞凋亡和心功能的影响[J].医学信息,2022,35(11):72.[doi:10.3969/j.issn.1006-1959.2022.11.020]
　HUANG Guang-ming,ZHAO Xing-chang,FU Xian-zhao.Effects of Aquatic Therapeutic Exercise Combined with Traditional Chinese Medicine Internal Treatment on Cardiomyocyte Apoptosis and Cardiac Function in Diabetic Rats[J].Journal of Medical Information,2022,35(16):72.[doi:10.3969/j.issn.1006-1959.2022.11.020]
[8]何玲玲,程淑芬.曲美他嗪联合琥珀酸美托洛尔治疗冠心病心力衰竭疗效观察[J].医学信息,2018,31(13):142.[doi:10.3969/j.issn.1006-1959.2018.13.042]
　HE Ling-ling,CHENG Shu-fen.Therapeutic Effect of Trimetazidine Combined with Metoprolol Succinate in the Treatment of Coronary Heart Disease with Heart Failure[J].Journal of Medical Information,2018,31(16):142.[doi:10.3969/j.issn.1006-1959.2018.13.042]
[9]赵 维,廖荣宏,王爱华.糖皮质激素治疗心力衰竭疗效与安全性的Meta分析[J].医学信息,2018,31(14):70.[doi:10.3969/j.issn.1006-1959.2018.14.021]
　ZHAO Wei,LIAO Rong-hong,WANG Ai-hua.Meta-analysis of the Efficacy and Safety of Glucocorticoids in the Treatment of Heart Failure[J].Journal of Medical Information,2018,31(16):70.[doi:10.3969/j.issn.1006-1959.2018.14.021]
[10]李 宁,胡硕强.心脏再同步治疗心力衰竭的文献计量分析[J].医学信息,2018,31(19):79.[doi:10.3969/j.issn.1006-1959.2018.19.024]
　LI Ning,HU Shou-qiang.Bibliometric Analysis of Cardiac Resynchronization in the Treatment of Heart Failure[J].Journal of Medical Information,2018,31(16):79.[doi:10.3969/j.issn.1006-1959.2018.19.024]
[11]黎百志,李晓慧,张爱文.外周血线粒体DNA、生长分化因子-15联合脑钠肽检测对心力衰竭的诊断价值[J].医学信息,2023,36(12):86.[doi:10.3969/j.issn.1006-1959.2023.12.016]
　LI Bai-zhi,LI Xiao-hui,ZHANG Ai-wen.Diagnostic Value of Peripheral Blood Mitochondrial DNA, Growth Differentiation Factor-15 Combined with Brain Natriuretic Peptide in Patients with Heart Failure[J].Journal of Medical Information,2023,36(16):86.[doi:10.3969/j.issn.1006-1959.2023.12.016]

更新日期/Last Update: 2018-08-15